potenti
sirna
carrier
pulmonari
gene
deliveri
assess
encapsul
sirna
biodegrad
polyest
nanoparticl
consist
tertiaryaminemodifi
polyvinyl
alcohol
pva
backbon
graft
poli
llactidecoglycolid
plga
result
sirna
nanoparticl
prepar
use
solvent
displac
method
offer
advantag
form
small
nanoparticl
without
use
shear
forc
nanoparticl
character
regard
particl
size
zetapotenti
degrad
ph
use
dynam
static
light
scatter
sirna
releas
studi
perform
correl
nanoparticl
degrad
vitro
knockdown
firefli
luciferas
report
gene
use
assess
potenti
nanoparticl
sirna
carrier
human
lung
epitheli
cell
line
luc
aminemodifiedpvaplgasirna
nanoparticl
form
nm
particl
zetapotenti
mv
phosphat
buffer
salin
pb
break
nanoparticl
seen
within
h
pb
sustain
releas
sirna
nanoparticl
achiev
knockdown
luciferas
report
gene
pmol
antiluc
sirna
even
nebul
henc
conclud
aminemodifiedpvaplga
sirna
nanoparticl
could
promis
sirna
carrier
pulmonari
gene
deliveri
due
fast
degrad
potent
gene
knockdown
profil
gene
silenc
rna
interfer
rnai
offer
new
opportun
treatment
lung
diseas
lung
cancer
cystic
fibrosi
respiratori
syncyti
viru
rsv
sever
acut
respiratori
syndrom
sar
effect
deliveri
sirna
site
action
hinder
mani
biolog
barrier
ie
bifurc
lung
mucociliari
clearanc
lung
surfact
etc
across
barrier
number
addit
factor
taken
consider
sirna
quickli
inactiv
rnase
macrophag
henc
sirna
condens
encapsul
nonvir
sirna
carrier
afford
protect
host
defenc
requir
effici
lung
deposit
gener
defin
appropri
aerodynam
mean
diamet
droplet
dri
powder
rang
suffici
stabil
carrier
allow
nebul
deposit
lung
sirna
complex
size
particl
diamet
less
nm
avoid
macrophag
phagocytosi
effort
enhanc
gene
silenc
variou
nonvir
carrier
sirna
deliveri
develop
base
liposom
formul
posit
charg
polyc
nonbiodegrad
liposom
formul
shown
poor
sirna
carrier
pulmonari
gene
deliveri
possibl
due
surfact
inher
lung
design
biodegrad
polymer
materi
becom
import
object
avoid
acut
toxic
accumul
nanocarri
lung
administr
sirna
polyplex
form
biodegrad
poli
amino
ester
glycol
urethan
shown
display
low
cytotox
combin
fast
sirna
releas
sirna
polyplex
lead
effici
gene
silenc
vitro
recent
studi
report
chitosan
potenti
carrier
sirna
deliveri
howev
none
investig
degrad
correl
sirna
releas
knockdown
effici
poli
lacticcoglycol
acid
plga
nanoparticl
frequent
use
encapsul
peptid
protein
pdna
breakdown
plga
lead
acid
degrad
product
lactic
glycol
acid
caus
dna
degrad
damag
nanoparticl
abl
mediat
pronounc
dna
transfect
effici
possibl
due
poor
encapsul
low
cellular
uptak
insuffici
lysosom
escap
previous
mention
dna
degrad
attempt
overcom
drawback
branch
biodegrad
polyest
design
attach
hydrophil
posit
charg
amin
group
onto
hydrophil
watersolubl
backbon
consist
poli
vinyl
alcohol
subsequ
graft
multipl
plga
side
chain
studi
focus
deriv
poli
vinyl
dialkylamino
alkylcarbamatecovinyl
acetatecovinyl
alcohol
graftpoli
llactidecoglycolid
contain
diethylaminopropylamin
deapa
amin
function
composit
deapa
pvaplga
abbrevi
p
polym
found
use
pdna
contain
nanoparticl
show
surprisingli
high
transfect
effici
mechan
transfect
reli
protonspong
effect
backbon
rather
rapid
degrad
rate
biocompat
p
found
superior
poli
ethylen
imin
acut
toxic
inflammatori
respons
p
nanoparticl
pulmonari
applic
compar
low
degrad
rate
profil
affect
polym
structur
rapid
degrad
rate
achiev
studi
investig
hypothesi
nanoparticl
gener
rapidli
biodegrad
polym
could
advantag
intracellular
sirna
deliveri
nanoparticl
prepar
modifi
solvent
displac
method
encapsul
sirna
biodegrad
p
mild
condit
nanocarri
character
respect
cytotox
transfect
effici
nebul
properti
assess
potenti
pulmonari
deliveri
system
sirna
biodegrad
branch
polyest
deapa
pvaplga
abbrevi
p
synthes
character
previous
describ
antiluciferas
sirna
cat
sicontrol
nontarget
sirna
cat
purchas
dharmacon
lafayett
co
usa
lipofectamin
obtain
invitrogen
ca
usa
nanoparticl
prepar
use
solvent
displac
method
describ
jung
et
al
briefli
mg
p
dissolv
dri
aceton
stir
h
steril
laminar
flow
hood
sirna
dispers
p
aceton
solut
polym
ratio
rang
n
p
ratio
amount
polym
rang
p
tertiari
amin
per
da
mixtur
immedi
inject
poloxam
pluron
sigmaaldrich
munich
germani
aqueou
solut
whereupon
solut
immedi
turn
opalesc
aceton
remov
nanoparticl
suspens
evapor
laminar
flow
h
mtorr
vacuum
pump
min
sirna
nanoparticl
filter
poloxam
solut
ml
use
preweigh
mm
whatman
filter
disc
filter
disc
wash
ml
distil
water
allow
dri
vacuum
constant
weight
determin
concentr
nanoparticl
suspens
supernat
analyz
sirna
concentr
ethidium
bromid
intercal
assay
min
incub
iu
heparin
twenti
mgml
ethidium
bromid
solut
ad
fluoresc
measur
use
fluoresc
plate
reader
ls
b
perkin
elmer
germani
excit
emiss
wavelength
nm
nm
respect
amount
sirna
calcul
calibr
curv
rang
sirna
experi
carri
triplic
prepar
nanoparticl
suspens
pipet
directli
onto
membran
steril
aeroneb
laboratori
nebul
aerosol
collect
condens
use
ml
eppendorf
tube
press
bottom
nebul
typic
recoveri
aerosol
experi
carri
quadrupl
nanoparticl
suspens
dilut
nacl
solut
dilut
solut
place
aeroneb
laboratori
nebul
stream
nitrogen
lmin
use
propel
aerosol
laser
beam
fraunhof
laser
diffractor
six
measur
taken
formul
sodium
chlorid
serv
control
droplet
size
express
mass
median
aerodynam
diamet
mmad
measur
particl
size
zetapotenti
hydrodynam
diamet
nanoparticl
suspens
measur
photon
correl
spectroscopi
pc
use
zetas
nano
zs
malvern
instrument
herrenberg
germani
nanoparticl
prepar
total
volum
differ
np
ratio
contain
pmol
sirna
determin
zetapotenti
nanoparticl
suspens
dilut
either
distil
water
hepe
buffer
glucos
hbg
glucos
buffer
mm
hepe
measur
given
mean
valu
three
independ
run
perform
triplic
studi
nanoparticl
stabil
anion
heparin
competit
assay
perform
heparin
dissolv
pure
water
obtain
concentr
rang
iu
per
sirna
ad
nanoparticl
suspens
lipofectaminesirna
pei
kdasirna
polyplex
solut
incub
min
rt
solut
fill
final
volum
mix
mgml
ethidium
bromid
solut
fluoresc
measur
use
fluoresc
plate
reader
ls
b
perkin
elmer
germani
excit
emiss
wavelength
nm
nm
respect
free
sirna
calcul
calibr
curv
rang
sirna
result
given
mean
triplic
measur
nanoparticl
suspens
n
p
ratio
contain
antiluc
sirna
dilut
phosphat
buffer
salin
ph
low
volum
eppendorf
uvett
hydrodynam
diamet
light
scatter
kilo
count
per
second
kcp
measur
taken
everi
min
use
zetas
nano
zs
malvern
instrument
time
point
measur
sextuplet
per
measur
total
measur
min
sirna
releas
studi
ph
nanoparticl
suspens
n
p
ratio
dilut
phosphat
buffer
salin
ph
total
volum
incub
differ
time
point
h
h
h
h
h
h
h
aliquot
nanoparticl
suspens
centrifug
min
pellet
separ
supernat
incub
iu
heparin
min
sirna
quantifi
use
ethidium
bromid
intercal
assay
describ
effici
nanoparticl
format
sirna
encapsul
valu
calcul
mean
sd
three
experi
luc
cell
stabli
express
luciferas
cultur
rpmi
medium
supplement
heat
inactiv
fetal
bovin
serum
twentyfour
hour
transfect
cell
seed
plate
densiti
per
well
nanoparticl
prepar
describ
pmol
sirna
suspens
ad
well
contain
fresh
rpmi
h
incub
medium
replac
cell
allow
grow
h
addit
antiluc
sirna
nonsilenc
sirna
sequenc
use
ensur
decreas
luciferas
express
due
antiluciferas
sirna
cytotox
effect
vector
lipofectamin
invitrogen
carlsbad
usa
use
posit
control
sirna
deliveri
prepar
accord
manufactur
protocol
luciferas
gene
silenc
activ
measur
accord
protocol
provid
promega
madison
wi
usa
briefli
cell
lyse
cell
cultur
lysi
buffer
min
luciferas
activ
quantifi
inject
luciferas
assay
buffer
contain
mm
luciferin
cell
lysat
rel
light
unit
rlu
measur
plate
luminomet
lumistar
optima
bmg
labtech
gmbh
offenburg
germani
experi
perform
quadrupl
data
express
percentag
control
untreat
cell
twentyfour
hour
transfect
luc
cell
seed
plate
densiti
per
well
nanoparticl
suspens
serial
dilut
fetal
bovin
serum
mgml
mgml
total
nine
concentr
quadrupl
measur
made
concentr
use
dilut
suspens
allow
incub
h
luc
cell
medium
remov
rpmi
plu
mgml
mtt
bromid
solut
ad
well
incub
h
mtt
medium
remov
formazan
dissolv
use
dmso
absorb
measur
nm
background
nm
subtract
cell
viabil
nanoparticl
concentr
absorb
blank
cell
absorb
data
present
mean
four
measur
ld
calcul
use
boltzman
sigmoid
function
microc
v
originlab
northampton
usa
hemolyt
activ
nanoparticl
polyplex
investig
report
earlier
briefli
human
erythrocyt
isol
fresh
citrat
blood
healthi
volunt
centrifug
red
blood
cell
wash
pb
supernat
clear
erythrocyt
dilut
pb
cellsml
nanoparticl
suspens
prepar
explain
prepar
nanoparticl
suspens
pb
triton
pb
use
control
lysi
lysi
respect
aliquot
nanoparticl
suspens
mix
erythrocyt
suspens
sampl
incub
min
constant
shake
centrifug
supernat
analyz
hemoglobin
releas
nm
signific
mean
valu
calcul
use
unpair
student
ttest
probabl
valu
p
b
mark
p
b
mark
p
b
mark
p
polym
prepar
character
describ
wittmar
et
al
physic
properti
p
w
kda
n
kda
pdi
g
nanoparticl
suspens
prepar
dissolv
p
polym
fig
nonwat
solubl
aceton
sirna
dissolv
buffer
inject
directli
aceton
solut
solut
immedi
turn
opalesc
nanoparticl
format
phenomenon
also
known
marangoni
effect
format
nanoparticl
solvent
displac
method
offer
sever
benefit
tradit
method
exampl
high
speed
mix
avoid
prevent
shear
forc
sirna
nanoparticl
solvent
displac
also
allow
scale
nanoparticl
format
modifi
larg
batch
size
small
volum
sirna
nanoparticl
remov
aceton
reduc
pressur
allow
faster
prepar
affect
nanoparticl
term
hydrodynam
diamet
zetapotenti
transfect
investig
effici
nanoparticl
format
sirna
encapsul
show
p
polym
n
p
nitrogen
phosphat
ratio
form
nanoparticl
could
filter
filter
supernat
contain
total
sirna
translat
associ
inject
sirna
p
nanoparticl
compar
favour
formul
chitosan
coat
plga
nanoparticl
sirna
encapsul
p
nanoparticl
similar
encapsul
effici
oligonucleotid
liposom
well
chitosantpp
encapsul
nanoparticl
physicochem
properti
p
nanoparticl
nanoparticl
formul
prepar
vari
ratio
amin
function
polym
backbon
phosphat
group
sirna
abbrevi
n
p
ratio
nanoparticl
size
surfac
charg
character
dynam
light
scatter
dl
zetapotenti
respect
increas
n
p
ratio
size
increas
nm
n
p
nm
n
p
seen
fig
observ
like
due
higher
polym
concentr
organ
phase
use
higher
n
p
ratio
quintanarguerrero
cowork
studi
factor
control
nanoparticl
size
solvent
displac
method
result
demonstr
polym
concentr
organ
phase
affect
particl
sizesth
higher
concentr
larger
particl
size
sirna
concentr
aceton
volum
constant
concentr
p
polym
chang
yield
differ
n
p
ratio
overal
type
sirna
antiluc
sirna
nonspecif
influenc
size
expect
zetapotenti
p
nanoparticl
vari
salt
concentr
zetapotenti
vari
n
p
ratio
presenc
absenc
sirna
particl
size
polym
inject
method
ie
syring
versu
plastic
pipett
tip
inject
solutesalt
concentr
mm
zetapotenti
alway
seen
rang
mv
nanoparticl
suspens
dilut
isoton
salin
solut
zetapotenti
went
mv
stabil
sirna
carrier
alway
utmost
import
possibl
therapeut
formul
would
integr
formul
would
use
sever
hour
later
monitor
integr
p
nanoparticl
dl
measur
record
h
freshli
prepar
sampl
n
p
nanoparticl
suspens
poloxam
ph
contain
antiluc
sirna
fig
demonstr
nanoparticl
suspens
aggreg
display
gross
degrad
throughout
h
incub
period
hydrodynam
diamet
remain
constant
start
particl
size
nm
close
particl
size
nm
end
experi
slight
increas
scatter
intens
seen
like
result
solvent
evapor
stabil
nanoparticl
allow
time
flexibl
character
transfect
experi
often
possibl
polyplex
lipoplex
exampl
lipofectamin
lipoplex
need
use
within
min
optimum
gene
knockdown
p
nanoparticl
display
notic
differ
transfect
within
h
prepar
data
shown
futur
experi
explor
long
longterm
stabil
p
nanoparticl
effect
vitro
transfect
nebul
p
nanoparticl
carri
use
aeroneb
laboratori
nebul
devic
use
ultrason
vibrat
mesh
nebul
aqueou
medium
aerosol
nebul
advantag
airjet
nebul
higher
output
result
less
shear
forc
due
nomin
exposur
time
oligonucleotid
ultrason
energi
known
alter
undermin
aerosol
drug
formul
thu
p
nanoparticl
character
nebul
seen
fig
lowest
ratio
n
p
affect
nebul
n
p
ratio
increas
hydrodynam
diamet
zetapotenti
larger
increas
standard
deviat
increas
like
caus
ultrasound
induc
aggreg
nanoparticl
n
p
ratio
signific
effect
seen
either
particl
size
surfac
potenti
unpair
student
ttest
p
b
size
nebul
aerosol
import
lung
deposit
deapa
p
nanoparticl
gener
size
rang
adequ
deposit
human
lung
rang
comparison
salin
poloxam
aerosol
measur
laser
diffract
determin
mass
median
aerodynam
diamet
mmad
aeroneb
laboratori
nebul
claim
produc
aerosol
rang
median
size
rang
respect
addit
nanoparticl
suspens
dilut
fig
effect
nebul
p
particl
size
b
zetapotenti
salin
littl
effect
mmad
size
rang
major
dosag
would
avail
therapeut
lung
deposit
effici
sirna
deliveri
cytosol
strength
electrostat
interact
sirna
transport
vehicl
major
import
polym
high
charg
densiti
pei
might
form
insepar
complex
sirna
imped
releas
cytosol
high
knockdown
effici
sirna
formul
stabl
cellular
uptak
releas
sirna
cytosol
bind
rnainduc
silenc
complex
risc
exert
biolog
activ
investig
electrostat
interact
p
sirna
heparin
competit
assay
perform
pei
kda
typic
exampl
polyplex
lipofectamin
lipoplex
includ
comparison
accord
low
knockdown
effici
pei
kda
luc
cell
pei
display
strong
electrostat
rna
bind
releas
sirna
pei
polyplex
iu
heparin
requir
least
iu
heparin
necessari
releas
sirna
shown
fig
contrast
p
nanoparticl
form
suffici
stabl
nanocarri
nebul
endocytot
uptak
see
vitro
biolog
activ
electrostat
bind
high
allow
suffici
releas
sirna
buffer
possibl
cytoplasm
iu
heparin
necessari
releas
sirna
nanoparticl
iu
heparin
releas
sirna
much
smaller
bind
affin
p
polym
due
type
densiti
amin
present
tertiari
dimethyl
amin
incorpor
p
less
proton
pei
primari
amin
therefor
less
electrostat
affin
phosphat
group
sirna
comparison
pei
amin
densiti
also
time
less
daamin
p
versu
daamin
pei
two
properti
combin
ensur
sirna
weakli
bound
within
p
nanoparticl
upon
p
degrad
sirna
abl
free
degrad
byproduct
case
lipofectamin
sirna
could
releas
lipoplex
heparin
howev
recent
studi
show
lipoplex
decomplex
easili
polyplex
explain
fusogen
properti
cell
membran
lead
releas
sirna
nanoparticl
degrad
sirna
releas
ph
mention
biodegrad
key
factor
longterm
pulmonari
applic
avoid
sideeffect
caus
accumul
first
breakthrough
pulmonari
drug
deliveri
achiev
plga
microparticl
due
low
toxic
biodegrad
charact
drawback
plga
microparticl
slow
degrad
rate
could
vari
week
month
wittmar
et
al
therefor
synthes
new
class
deapapvaplga
polym
much
faster
degrad
rate
introduc
hydrophil
amin
group
studi
degrad
profil
p
nanoparticl
physiolog
condit
static
light
scatter
use
degrad
p
nanoparticl
particl
shown
depend
ph
solut
poloxam
ph
fig
mm
acet
buffer
ph
data
shown
display
min
physiolog
ph
degrad
nanoparticl
complet
less
min
ph
phosphat
buffer
salin
min
seen
fig
accord
result
obtain
static
light
scatter
sirna
releas
studi
phosphat
buffer
ph
show
releas
first
h
h
incub
nearli
complet
releas
achiev
free
sirna
rapid
rate
sirna
releas
correl
degrad
sirna
carrier
demonstr
sirna
carrier
knowledg
similar
behaviour
shown
tseng
et
al
formul
biodegrad
poli
amino
ester
glycol
urethan
sirna
polyplex
could
show
maximum
sirna
releas
h
incub
pb
ph
rapid
biodegrad
posit
effect
biocompat
like
contribut
rapid
releas
sirna
insid
cytosol
endocytot
escap
wherea
acid
endosom
ph
would
littl
degrad
sirna
would
remain
protect
encapsul
exactli
p
nanoparticl
escap
lysosom
remain
investig
detail
lipoplex
known
escap
endosom
fusion
mechan
cell
membran
cation
polym
polyethylenimin
pei
thought
releas
endosom
socal
protonspong
effect
possibl
local
membran
damag
present
escap
mechan
p
nanoparticl
known
remain
determin
separ
studi
specul
osmot
effect
also
interact
endosom
membran
could
play
role
interact
would
disrupt
membran
potenti
gener
membran
bound
atpas
keep
ph
near
extracellular
cytosol
ph
degrad
p
sirna
rapid
subsequ
releas
sirna
would
find
way
cytosol
studi
way
clarifi
mechanist
aspect
sirna
deliveri
use
p
nanoparticl
cytotox
p
nanoparticl
evalu
toxic
pure
p
nanoparticl
p
nanoparticl
mtt
assay
rbc
hemolysi
assay
perform
pei
kda
serv
comparison
case
illustr
fig
cell
treat
pure
p
nanoparticl
p
nanoparticl
show
rel
high
cell
viabil
comparison
pei
kda
ld
p
nanoparticl
display
lower
toxic
ld
encapsul
sirna
nanoparticl
decreas
cytotox
ld
show
differ
unencapsul
nanoparticl
effect
like
due
neg
charg
sirna
shield
neutral
toxic
p
cation
charg
erythrocyt
one
use
cellular
membran
model
rbc
hemolysi
experi
serv
model
assay
investig
membran
interact
p
cell
depict
fig
erythrocyt
hemolys
treat
pei
kda
contrast
incub
p
nanoparticl
without
sirna
equival
deapa
polym
significantli
reduc
erythrocyt
lysi
led
hemolysi
p
nanoparticl
without
encapsul
sirna
shown
three
time
less
hemolyt
pei
p
sirna
formul
display
seven
time
less
toxic
membran
interact
vitro
biolog
activ
p
nanoparticl
transfect
effici
p
nanoparticl
assess
human
lung
epitheli
cell
line
luc
cell
line
stabli
transfect
express
firefli
luciferas
nanoparticl
suspens
formul
antiluc
sirna
specif
target
firefli
luciferas
mrna
nonspecif
sirna
control
least
four
mismatch
known
human
gene
fig
display
result
seven
differ
n
p
ratio
three
differ
sirna
dose
effect
sirna
carrier
luciferas
mrna
cleavag
less
luciferas
protein
express
contrast
use
nonspecif
sirna
decreas
luciferas
observ
p
nanoparticl
affect
cell
metabol
caus
cytotox
p
nanoparticlessirna
pmol
ng
sirna
fig
formul
n
p
ratio
display
luciferas
specif
knockdown
level
compar
untreat
luc
cell
control
nonspecif
knockdown
low
luciferas
activ
compar
control
seen
largest
n
p
ratio
pmol
nanoparticl
suspens
achiev
higher
level
antiluc
sirna
knockdown
control
optimum
n
p
ratio
pmol
ng
sirna
fig
dosag
compar
lipofectamin
commerci
transfect
reagent
highest
sirna
dosag
test
pmol
fig
antiluc
sirna
knockdown
greatest
valu
control
howev
pmol
sirna
nonspecif
sirna
knockdown
seen
dose
depend
manner
like
caus
p
induc
cytotox
polyethylenimin
pei
kda
use
neg
control
known
highli
effici
standard
transfect
reagent
pdna
display
less
promis
gene
silenc
case
sirna
strong
electrostat
interact
sirna
shown
use
heparin
bind
assay
like
result
low
knockdown
effici
due
incomplet
sirna
releas
cytosol
design
p
sirna
formul
allow
favour
releas
sirna
due
number
factor
highli
posit
surfac
charg
mv
ensur
bind
nanoparticl
neg
charg
cell
membran
uptak
take
place
insid
endosom
interact
posit
charg
hydrophob
nanoparticl
endosom
membran
similar
way
hypothes
pei
would
lead
destabil
local
membran
damag
water
influx
follow
neutral
acid
lysosom
environ
would
caus
hydrolyt
enzymat
degrad
plga
chain
byproduct
result
osmot
pressur
increas
therebi
lead
water
influx
ultim
ruptur
endosom
cytosol
ph
degrad
p
nanoparticl
fast
subsequ
releas
sirna
occur
rapid
uptak
endolysosom
releas
less
min
also
seen
plga
nanoparticl
factor
like
contribut
high
luciferas
knockdown
seen
small
sirna
dosag
pmol
effect
nebul
vitro
biolog
activ
p
sirna
nanoparticl
nebul
p
nanoparticl
shown
effect
size
standard
deviat
nanoparticl
suspens
low
n
p
ratio
see
fig
also
seen
transfect
sirna
fig
display
result
two
n
p
ratio
test
effect
nebul
condens
nonspecif
sirna
effect
seen
either
n
p
ratio
sirna
dosag
data
conclud
nebul
effect
cytotox
properti
nanoparticl
suspens
n
p
ratio
nebul
caus
signific
decreas
pmol
sirna
dosag
unpair
student
ttest
averag
increas
luciferas
knockdown
activ
nebul
n
p
ratio
caus
decreas
sirna
transfect
observ
nebul
n
p
ratio
might
link
result
seen
particl
size
nebul
mean
particl
size
increas
nm
nm
increas
size
nanoparticl
suspens
make
much
differ
n
p
ratio
similar
particl
size
nm
transfect
result
affect
nebul
data
shown
instead
vibrat
energi
nebul
may
disrupt
behaviour
smaller
n
p
due
smaller
particl
size
increas
proport
sirna
carri
disrupt
effect
possibl
lead
less
sirna
encapsul
nanoparticl
degrad
faster
observ
therefor
less
sirna
deliv
luc
cell
higher
n
p
ratio
nebul
effect
sirna
knockdown
luciferas
formul
nebul
luciferas
knockdown
data
consider
aerosol
droplet
size
demonstr
potenti
p
nanoparticl
ratio
higher
act
sirna
carrier
potenti
pulmonari
deliveri
design
formul
sirna
carrier
gene
therapi
last
year
led
broad
panel
variou
liposom
cation
polym
vector
liposomemedi
deliveri
show
effici
knockdown
vitro
ineffici
appli
vivo
via
instil
among
polymer
vector
deriv
pei
degrad
oligoethylenimin
pegyl
pei
low
molecular
weight
fraction
pei
use
sirna
carrier
sirna
carrier
other
slowli
elucid
necessari
ideal
carrier
ideal
sirna
carrier
aerosol
gene
therapi
need
meet
follow
requir
protect
sirna
high
shear
forc
nanoparticl
format
nebul
ii
fast
degrad
rate
nontox
byproduct
target
site
iii
releas
sirna
cytosol
effect
gene
silenc
design
branch
polyest
consist
aminemodifi
pva
backbon
graft
plga
chain
test
see
polym
could
meet
requir
need
use
sirna
carrier
sirna
shown
encapsul
absorb
greater
effici
nanoparticl
encapsul
sirna
protect
remain
intact
nanoparticl
format
nebul
particl
size
transfect
result
demonstr
antiluc
sirna
remain
activ
luciferas
long
n
p
ratio
formul
breakdown
nanoparticl
within
h
shown
static
light
scatter
lead
rapid
releas
sirna
though
could
challeng
vivo
gene
deliveri
physiolog
fluid
also
within
rapid
degrad
ph
rang
high
surfac
potenti
p
nanoparticl
make
like
taken
lung
cell
quickli
upon
aerosol
deposit
nebul
nanoparticl
suspens
minor
effect
vitro
biolog
activ
lowest
n
p
ratio
issu
could
easili
overcom
increas
n
p
ratio
n
p
ratio
nebul
p
nanoparticl
display
compar
knockdown
effici
nonnebul
sampl
small
sirna
dosag
pmol
necessari
achiev
luciferas
knockdown
minor
cytotox
combin
featur
fast
degrad
combin
low
cytotox
nanoparticl
stabil
nebul
high
specif
knockdown
make
p
polym
promis
sirna
carrier
pulmonari
gene
therapi
futur
vivo
studi
